Prostate Cancer Treatment in Cedar Rapids
Our partners offer a variety of prostate cancer treatment options to our patients. St. Luke's and Physicians' Clinic of Iowa Urology are among the first hospitals in the state to offer a new prostate cancer treatment called Radium 223. The Nassif St. Luke's Radiation Center is the only provider in Cedar Rapids to offer brachytherapy, a seed implantation technique that results in a shorter treatment time.
Radium-223 (Xofigo) Therapy
This treatment is appropriate for men with prostate cancer whose disease has spread to the bone, but not to other organs. This treatment is administered by injection of Radium-223 dichloride into a vein. This therapy is performed for as many as six times to achieve optimal effect with minimal side effects. The period between injections is approximately four weeks. The Radium-223 dichloride infusion is performed over 1-2 minutes.
Radium-223 dichloride is a radioactive drug which goes to the source of cancer bone pain and may alleviate pain associated with bone metastasis. Side effects are usually minimal. There may be a decrease in blood cells and blood samples that will be monitored before and after each therapy administration. You will be able to continue all activities that you are already doing.
Learn more about this treatment from the American Cancer Society.
View this informational video about Radium 223:
Low Dose Rate (LDR) Brachytherapy
Seed implantation, also called brachytherapy, is a common treatment option for early stage prostate cancer. A benefit for men who choose the implants is a shorter treatment time than for treatment done with an external source. The Nassif St. Luke's Radiation Center is the only provider of this service in Cedar Rapids.
Learn more about this treatment.